半月板中央化在胫骨高位截骨治疗内侧半月板后根撕裂的疗效分析

注册号:

Registration number:

ChiCTR2500097913 

最近更新日期:

Date of Last Refreshed on:

2025-02-27 10:56:52 

注册时间:

Date of Registration:

2025-02-27 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

半月板中央化在胫骨高位截骨治疗内侧半月板后根撕裂的疗效分析

Public title:

Clinical effect of meniscal centralization in high tibial osteotomy for medial meniscus posterior root tear

注册题目简写:

English Acronym:

研究课题的正式科学名称:

半月板中央化在胫骨高位截骨治疗内侧半月板后根撕裂的疗效分析

Scientific title:

Clinical effect of meniscal centralization in high tibial osteotomy for medial meniscus posterior root tear

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张雷 

研究负责人:

杨国敬 

Applicant:

Lei Zhang 

Study leader:

Guojing Yang 

申请注册联系人电话:

Applicant telephone:

+86 135 8755 7573

研究负责人电话:

Study leader's
telephone:

+86 137 0578 0048

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zhanglei@wmu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

1865068@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

浙江省温州市瑞安市万松路108号

研究负责人通讯地址:

浙江省温州市瑞安市万松路108号

Applicant address:

No.108, Wansong Rd, Ruian, Wenzhou, Zhejiang

Study leader's address:

No.108, Wansong Rd, Ruian, Wenzhou, Zhejiang

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

瑞安市人民医院

Applicant's institution:

Ruian People's Hospital

研究负责人所在单位:

瑞安市人民医院

Affiliation of the Leader:

Ruian People's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

YJ2022032

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

瑞安市人民医院伦理委员会

Name of the ethic committee:

IRB of Ruian People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2022-08-10 00:00:00

伦理委员会联系人:

潘可平

Contact Name of the ethic committee:

Keping Pan

伦理委员会联系地址:

浙江省温州市瑞安市万松路108号

Contact Address of the ethic committee:

No.108, Wansong Rd, Ruian, Wenzhou, Zhejiang

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 577 6586 6356

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

瑞安市人民医院

Primary sponsor:

Ruian People's Hospital

研究实施负责(组长)单位地址:

浙江省温州市瑞安市万松路108号

Primary sponsor's address:

No.108, Wansong Rd, Ruian, Wenzhou, Zhejiang

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江

市(区县):

温州

Country:

China

Province:

Zhejiang

City:

Wenzhou

单位(医院):

瑞安市人民医院

具体地址:

浙江省温州市瑞安市万松路108号

Institution
hospital:

Ruian People's Hospital

Address:

No.108, Wansong Rd, Ruian, Wenzhou, Zhejiang

国家:

中国

省(直辖市):

浙江

市(区县):

温州

Country:

China

Province:

Zhejiang

City:

Wenzhou

单位(医院):

温州医科大学附属第一医院

具体地址:

浙江省温州市瓯海区上蔡村

Institution
hospital:

The First Affiliated Hospital of Wenzhou Medical University

Address:

Shangcai Villege, Ouhai, Wenzhou, Zhejiang

经费或物资来源:

浙江省科学技术委员会

Source(s) of funding:

Zhejiang Municipal Commission of science and technology

研究疾病:

内侧半月板后根撕裂  

Target disease:

medial meniscus posterior root tear

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究旨在比较内侧半月板后根撕裂患者在胫骨高位截骨伴/不必半月板中央化手术术后的临床、放射学和关节镜结果。  

Objectives of Study:

This study aimed to compare the clinical, radiographic, and arthroscopic outcomes between high tibial osteotomy with or without meniscal centralization in patients with medial meniscus posterior root tears.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1. 有膝关节损伤病史者; 2. 外侧半月板撕裂或盘状半月板; 3. 膝关节不稳; 4. 膝关节内翻畸形> 10°或屈曲挛缩> 10°; 5. 严重髌股关节炎患者; 6. 伴有过度骨侵蚀或膝关节半脱位的严重内侧室间骨关节炎患者; 7. 未完成随访的患者。

Exclusion criteria:

1. Those with a history of knee injury; 2. Lateral meniscus tear or discoid meniscus; 3. Knee instability; 4. Knee varus deformity > 10° or flexion contracture > 10°; 5. Patients with severe patellofemoral arthritis; 6. Patients with severe medial interventricular osteoarthritis with excessive bone erosion or knee subluxation; 7. Patients who did not complete follow-up.

研究实施时间:

Study execute time:

From 2022-08-11 00:00:00 To 2024-08-10 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-08-12 00:00:00 To 2024-05-10 00:00:00

干预措施:

Interventions:

组别:

A组

样本量:

44

Group:

Group A

Sample size:

干预措施:

单纯接受HTO手术

干预措施代码:

Intervention:

Patients underwent HTO alone

Intervention code:

组别:

B组

样本量:

38

Group:

Group B

Sample size:

干预措施:

接受HTO及半月板中央化手术

干预措施代码:

Intervention:

Patients underwent HTO with concurrent meniscal centralization

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

浙江 

市(区县):

温州 

Country:

China

Province:

Zhejiang

City:

Wenzhou

单位(医院):

瑞安市人民医院 

单位级别:

三甲 

Institution
hospital:

Ruian People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

浙江 

市(区县):

温州 

Country:

China

Province:

Zhejiang

City:

Wenzhou

单位(医院):

温州医科大学附属第一医院 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of Wenzhou Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

临床评分(HSS and Lysholm评分)

指标类型:

主要指标

Outcome:

Clinical scores (HSS and Lysholm score)

Type:

Primary indicator

测量时间点:

术后1、3、6、12月及2年

测量方法:

Measure time point of outcome:

At 1, 3, 6, 12 month and 2 years postoperatively

Measure method:

指标中文名:

影像学评估(HKA、MPTA、JLCA、PTS)

指标类型:

次要指标

Outcome:

Radiographic variables (HKA,MPTA,JLCA,PTS)

Type:

Secondary indicator

测量时间点:

术后1、3、6、12月及2年

测量方法:

Measure time point of outcome:

At 1, 3, 6, 12 month and 2 years postoperatively

Measure method:

指标中文名:

半月板愈合率

指标类型:

次要指标

Outcome:

Meniscal healing rate

Type:

Secondary indicator

测量时间点:

二次关节镜探查时

测量方法:

Measure time point of outcome:

At the time of second-look arthroscopy

Measure method:

指标中文名:

软骨磨损情况(Outerbridge分型)

指标类型:

次要指标

Outcome:

Catilage wear (Outerbridge classification)

Type:

Secondary indicator

测量时间点:

二次关节镜探查时

测量方法:

Measure time point of outcome:

At the time of second-look arthroscopy

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由邱建迪用计算机随机数字法产生随机序列

Randomization Procedure (please state who generates the random number sequence and by what method):

Randomized with a table of random computer-generated numbers by Qiu Jiandi

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

公开时间:2025年12月13日;http://www.medresman.org.cn/uc/project/projectedit.aspx?proj=11721

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Date: 2025/12/13; http://www.medresman.org.cn/uc/project/projectedit.aspx?proj=11721

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

使用CRF进行数据采集,由研究人员将数据录入EXCEL进行数据管理,没有使用电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

We use CRF for data collection and input data into Excel for data management.The EDC is not using.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-02-27 10:56:43